https://www.cell.com/cell-reports/pdfExtended/S2211-1247(26)01057-0
I think this is a significant proof of my hypothesis relating to muscle cells and fits in with the 2021 Osteoporosis paper:
https://www.nature.com/articles/s43587-021-00105-8
chatGPT(Astra6,max,paid):
The uploaded paper is “mtDNA alterations in muscle progenitors determine myoblast differentiation and disrupt skeletal muscle architecture”, by Sen and colleagues, published in Cell Reports in 2026.
My assessment: The study provides convincing evidence that disrupting mitochondrial DNA maintenance can impair muscle-cell maturation and alter muscle fibre composition. Its claims about the transfer of damaged mtDNA from stem cells, and the resulting impairment of exercise performance, are less securely demonstrated.
Summary. The researchers manipulated Twinkle, the enzyme that unwinds mitochondrial DNA during replication. They expressed a disruptive variant, K320E, in cultured mouse muscle precursor cells and in mouse muscle stem cells.
The main findings were:
-
Muscle-cell differentiation stalled in culture. Control cells formed elongated, multinucleated myotubes. K320E cells largely failed to do so. Early differentiation markers, MyoD and myogenin, increased, but late muscle markers were strongly reduced. This suggests that cells entered the differentiation programme but failed to complete it.
-
Mitochondrial expansion and metabolism were disrupted. The normal increase in mtDNA copy number was blunted, and mitochondrial mass failed to increase normally. Respiratory complex assembly was disturbed, particularly Complex IV. Several mitochondrial proteins also decreased, including pyruvate dehydrogenase and TCA-cycle enzymes. Intact cells consumed more oxygen but showed greater proton leakage and lower ATP levels; isolated mitochondria had reduced respiratory capacity.
-
Oxidative stress contributed to the differentiation defect. The cytosolic oxidation-sensitive probe gave a higher signal, although the mitochondrial superoxide-sensitive probe gave a lower signal than in differentiated controls. Trolox, a vitamin E analogue, partially restored myotube formation and mitochondrial morphology. The rescue was incomplete.
-
The effect in regenerating mouse muscle was milder. Following experimentally induced injury, muscle stem cells still produced mature fibres. Some fibres had deficient respiratory enzyme staining, and mitochondrial oxidation signals changed during regeneration. The fluorescence differences largely subsided by eight weeks.
-
Early-life induction produced lasting changes in muscle structure. At 12 months, more mtDNA rearrangements were detected in whole muscle than in isolated muscle stem cells. Average fibre cross-sectional area was approximately 13% smaller at three months and 20% smaller at 12 months. Muscle composition shifted towards more oxidative fibre types, including increased type 2a fibres and the appearance of type 1 fibres. These changes occurred without detectable COX-deficient fibres in this experimental arm.
The authors interpret this as evidence that mtDNA instability originating in muscle progenitors can alter the properties of the muscle they generate.
Novelty. The broad connection between mtDNA disruption, impaired muscle regeneration and altered fibre composition was already established. A 2022 study involving several of the same researchers used the K320E model and reported impaired regeneration, smaller fibres, and a shift towards oxidative fibre types. Consequently, those findings should not be treated as entirely new here. (PMC)
The main additions are:
-
Detailed analysis of differentiation-associated mitochondrial remodelling. The paper connects the differentiation defect with changes extending beyond respiratory complexes to several nuclear-encoded mitochondrial proteins and metabolic enzymes.
-
Partial antioxidant rescue. This provides experimental evidence that altered redox conditions contribute to the cultured-cell phenotype.
-
The early postnatal model without deliberate muscle injury. Persistent changes in muscle architecture arise even when routine respiratory enzyme staining appears normal. This is probably the most interesting extension beyond the earlier work.
Critique. The study benefits from combining microscopy, gene-expression measurements, proteomics, respiratory assays, sequencing and mouse experiments. The authors also validate selected proteomic findings with western blots and acknowledge several limitations. However, some interpretations extend beyond what the experiments establish.
-
Transfer of pre-existing mtDNA damage is inferred rather than directly traced.
Finding few rearrangements in stem cells and more in mature muscle does not establish that individual damaged mtDNA molecules were passed from one compartment to the other.
The genetic intervention is activated in the stem-cell lineage, and descendants can retain K320E expression. New damage arising during or after differentiation therefore remains an alternative explanation. Different rates of mutation formation, elimination or expansion could also explain the distribution.
Demonstrating selective transfer would require tracking specific mtDNA variants through differentiation, ideally while switching off the damage-generating intervention. The results do not directly demonstrate asymmetric segregation of damaged mitochondria.
-
The experiments do not establish the same mechanism in natural ageing.
This is an engineered disruption of mtDNA maintenance. The authors acknowledge that they have not demonstrated the corresponding accumulation of mtDNA alterations in muscle stem cells during ordinary ageing.
The long-term experiment also starts shortly after birth. Developmental changes can therefore contribute to the adult phenotype. Moreover, K320E expression is stronger in cultured cells than in mice, complicating comparison of the severe culture phenotype with the milder animal phenotype.
-
Some metabolic changes could be consequences of failed differentiation.
By day eight, the comparison is between successfully differentiated control cells and poorly differentiated mutant cells. Their mitochondrial proteomes would be expected to differ because their developmental states differ.
Thus, reduced mitochondrial protein abundance could both contribute to, and result from, failed maturation. Earlier measurements and targeted rescue experiments would help establish the sequence.
The authors appropriately recognise another complication: proximity labelling measures proteins near the tagging enzyme. Reduced labelling can reflect changed protein location rather than reduced abundance. Their western blots confirm that both situations occur.
-
Normal COX staining does not establish normal mitochondrial function.
The early-life model supports the narrower conclusion that muscle remodelling can occur without an obvious COX histochemical defect. It does not exclude impaired ATP production, respiratory coupling or metabolite supply.
Likewise, the number of detected rearrangements does not establish a quantitative threshold linking the fraction of altered mtDNA in individual fibres to their function.
-
The exercise-performance claim needs clarification.
The text reports reduced high-speed running time in both sexes. However, Figure 7I does not visibly show a corresponding reduction in male running time. Its significance brackets also appear to compare slow and fast running within genotypes, rather than directly comparing control and mutant mice at the same speed.
This is an apparent inconsistency requiring clarification against the underlying data. With only three mutant and four control mice per sex, the exercise conclusion is considerably less robust than the cellular differentiation result.
-
The antioxidant experiment establishes contribution, not a complete mechanism.
Partial rescue by Trolox supports a role for redox disturbance. It does not establish that oxidative stress is the sole cause, identify the decisive reactive species, or demonstrate the proposed release of mitochondrial hydrogen peroxide into the cytosol.
For your citrate and acetyl-CoA hypothesis, the paper supports the upstream proposition that mitochondrial integrity and metabolic remodelling matter for completing differentiation. Reduced pyruvate dehydrogenase and several TCA-cycle proteins are compatible with altered metabolite supply, but protein abundance alone does not establish citrate flux or nuclear acetyl-CoA availability.
The study does not measure citrate export, nuclear acetyl-CoA, histone acetylation, RNA polymerase II stalling, splicing fidelity or a senescence-associated secretory phenotype. A particularly informative follow-up would measure these variables during differentiation and test whether restoring nuclear acetyl-CoA availability rescues maturation while the mtDNA defect remains.